Bodor Laboratories, Inc.
Records under this name other than the patents Bodor Laboratories, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 33 patents it holds.
Showing 1 to 5 of 5 · Back to Bodor Laboratories, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,628,759 | Soft Anticholinergic Esters Term ended Term ended Nov 13, 2026 · Medium confidence | Term ended | Term ended Nov 13, 2026 | Medium confidence |
| US 8,835,410 | Treatment of Eyelid Dermatitis Lapsed on the fee record Ended Sep 16, 2026 · High confidence | Lapsed on the fee record | Ended Sep 16, 2026 | High confidence |
| US 7,419,971 | Enhancement of activity and/or duration of action of selected anti-inflammatory steroids for topical or other local application Term ended Term ended Sep 14, 2025 · From the USPTO record | Term ended | Term ended Sep 14, 2025 | From the USPTO record |
| US 7,923,441 | Enhancement of activity and/or duration of action of soft anti-inflammatory steroids for topical or other local application Term ended Term ended Oct 16, 2024 · From the USPTO record | Term ended | Term ended Oct 16, 2024 | From the USPTO record |
| US 7,776,846 | Enhancement of activity and/or duration of action of selected anti-inflammatory steroids for topical or other local application Lapsed on the fee record Ended Aug 17, 2022 · From the USPTO record | Lapsed on the fee record | Ended Aug 17, 2022 | From the USPTO record |